Expression vector of fused protein of glutamine transporter 1 as well as construction method and application thereof
A technology of transporter and glutamine, applied in the field of bioengineering, can solve problems such as unsatisfactory effect, difficult membrane protein, and expensive antibody
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] Example 1 A large amount of acquisition of the original eukaryotic expression vector plasmid containing the SNAT1-HA gene and the vector plasmid containing the EGFP gene:
[0072] The original eukaryotic expression vector plasmid containing rat glutamine transporter 1 and HA tag protein fusion gene (SNAT1-HA) is pBK-CMV(Δ[1098-1300])-SNAT1-HA, containing enhanced green fluorescent protein ( EGFP) gene carrier plasmid is pMD-19T-EGFP.
[0073] Add lng of pBK-CMV(Δ[1098-1300])-SNAT1-HA or pMD-19T-EGFP plasmid to 100μl DH5α competent cells (TIANGEN company), rotate the centrifuge tube gently to mix the contents, and store in ice Stand in the bath for 30min. Place the centrifuge tube in a 42-degree ice bath for 60-90 seconds, then quickly transfer the tube to the ice bath to cool the cells for 2-3 minutes. Add 900 μl of sterile LB medium (without antibiotics) to each centrifuge tube, mix well, shake and culture at 37 degrees for 45 minutes (150 rpm), mix the contents, and...
Embodiment 2
[0076] The amplification of embodiment 2EGFP gene
[0077] Using the plasmid pMD-19T-EGFP obtained in Example 1 as a template, perform polymerase chain reaction to amplify the EGFP gene; reaction conditions: 94°C, 2min, one cycle; 94°C, denaturation for 30s, 66.1°C for 30s, 72°C Extend at ℃ for 60s, a total of 33 cycles; extend at 72°C for 20min. The reaction product was purified and recovered for sequencing identification and the construction of the fusion protein SNAT1-HA-EGFP vector in the next step;
[0078] The specific primers used for PCR amplification of EGFP gene are:
[0079] EGFP-P1: 5'-gaatctatta GCGGCCGC aatggtgagcaagggcgag-3',
[0080]EGFP-P2: 5'-ctatatagat GCGGCCGC tcacttgtacagctcgtccatg-3'.
[0081] The underlined part represents the NotI restriction site sequence;
Embodiment 3
[0082] Example 3 Construction of pBK-CMVΔ-SNAT1-HA-EGFP recombinant
[0083] (1) Take 5.0 μg of the pBK-CMVΔ-SNAT1-HA carrier plasmid obtained in Example 1, perform Not I single enzyme digestion reaction, incubate at 37° C. for 3 hours, and recover the large carrier fragment;
[0084] 4.0 μg of the PCR amplification product obtained in Example 2 was subjected to a Not I single enzyme digestion reaction, incubated at 37° C. for 10 hours, and the EGFP gene fragment was recovered;
[0085] (2) Ligate the vector large fragment and the EGFP small fragment with T4DNA ligase:
[0086] The digested and purified pBK-CMVΔ-SNAT1-HA carrier large fragment and EGFP small fragment were ligated at a molar ratio of 4:1, and the ligation condition was 16°C for 5 hours. The large fragment of pBK-CMVΔ-SNAT1-HA vector and the small fragment of EGFP were connected through the NotI restriction site.
[0087] The obtained vector pBK-CMVΔ-SNAT1-HA-EGFP recombinant plasmid is as follows figure 1 A...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com